Anti-JNK1 + JNK2 (phospho T183 + Y185) 抗体
Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody
3
(1 Review)
|
(36 Publications)
Rabbit Polyclonal JNK1 phospho Y185 + T183 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Rat, Human, Mouse samples. Cited in 36 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK8 pY185 + T183.
別名を表示する
JNK1, PRKM8, SAPK1, SAPK1C, MAPK8, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, JNK-46, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, SAPK1c
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)
Immunofluorescence analysis of methanol fixed HeLa cells labelled with ab131499 at 1/100 dilution.
- WB
Unknown
Western blot - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)
Secondary antibody - anti-rabbit HRP (ab6721)
All lanes:
Western blot - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (ab131499) at 1/500 dilution
Lane 1:
C6 cells treated with anisomycin
Lane 2:
Untreated C6 cells
Predicted band size: 48 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These enzymes play vital roles in regulating cellular responses to stress stimuli. JNK1 and JNK2 form part of larger signaling complexes including the JNK molecular weight complex that is activated in stressful conditions like UV radiation or cytokines. Once activated they phosphorylate transcription factors such as c-Jun leading to gene expression changes that facilitate adaptative and survival responses. They modulate cellular processes like apoptosis inflammation and cell differentiation clearly contributing to homeostasis and development.
Pathways
These kinases interact significantly within the MAPK (Mitogen-activated protein kinase) and apoptosis pathways. JNK proteins mediate signals from upstream kinases such as MKK4/7 and respond to inflammatory cytokines resulting in transcriptional alterations. Their downstream impact is tightly linked to apoptosis through interactions with Bcl-2 family members affecting cellular fate. ERK and p38 MAPK proteins closely interact with JNK pathways co-regulating cellular stress responses and survival pathways highlighting their importance in maintaining cellular balance.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (36)
Recent publications for all applications. Explore the full list and refine your search
Journal of neuroinflammation 21:178 PubMed39034417
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cytotechnology 76:153-166 PubMed38495298
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 327:121856 PubMed37307966
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical immunology (Orlando, Fla.) 245:109176 PubMed36368640
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36077357
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:1612829 PubMed35990822
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neurochemical research 47:3167-3177 PubMed35842555
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35887045
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 19:129 PubMed35658977
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bosnian journal of basic medical sciences 22:217-228 PubMed34813418
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com